CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $31,968,735
- in 3 filings, $32.0M under 10b5-1 plans
Net −$31,968,735. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −4,605 | $197.23 | $908K | 28,600 |
| 2026-09-08 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −2,562 | $198.05 | $507K | 26,038 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −2,635 | $180.29 | $475K | 167,934 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −2,587 | $181.24 | $469K | 165,347 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −3,413 | $182.50 | $623K | 161,934 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −4,955 | $183.30 | $908K | 156,979 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −6,252 | $184.52 | $1.2M | 150,727 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −4,593 | $185.34 | $851K | 146,134 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −7,800 | $186.32 | $1.5M | 138,334 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −6,200 | $187.25 | $1.2M | 132,134 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −3,045 | $188.26 | $573K | 129,089 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −8,955 | $189.34 | $1.7M | 120,134 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −600 | $190.39 | $114K | 119,534 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −11,080 | $191.15 | $2.1M | 108,454 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −4,209 | $192.54 | $810K | 104,245 |
| 2026-09-04 | Lin Yu-Hsin Chief Executive Officer | Sale 10b5-1 | −8,111 | $193.13 | $1.6M | 96,134 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −1,633 | $180.16 | $294K | 91,800 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −2,000 | $181.05 | $362K | 89,800 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −2,000 | $182.49 | $365K | 87,800 |
| 2026-09-04 | Chuang Hao-Yuan Chief Financial Officer | Sale 10b5-1 | −3,759 | $183.27 | $689K | 84,041 |
Page 2 of 10 · 186 trades